Nathalie Fuentes shared her experience of landing a unicorn position in a pharmaceutical company after a postdoctoral ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

SMi Reports: New brochure released for the 2019 Pharmaceutical Cleanroom Technology ... addressing the microbiological aspects in cleanroom design and engineering. For delegate enquiries, please ...

Collaborative telehealth platform will provide patients with immediate access to QSYMIA®, a chronic weight loss medication, enhancing their ...

Information Services Group (ISG) , a leading global technology research and advisory firm, has launched a new research study examining the emerging ecosystem of providers that support their clients' ...

In this interview, News Medical speaks with Dr Martin Biggs from Synoptics about Syngene's G:Box, a high-quality imaging and gel documentation system.

Nxera Pharma, previously known as Sosei Heptares or the Sosei Group, has entered a collaboration and licensing agreement with Antiverse to design antibodies for G-protein coupled receptors (GPCRs).

Design and digital innovation can play a vital role in renewing audiences’ trust in pharma brands and helping engage Gen Z, says Troy Polsley of creative agency Minds + Assembly Americans trust pharma ...

Tokyo, Japan and London and Cardiff, UK, 5 November 2024 – Nxera Pharma (“Nxera”; TSE 4565 ... partnership and licensing agreement to design antibodies for G-protein coupled receptors ...

Matt Barnes, EVP, President of Nxera Pharma UK and Head of R&D, said: “Our NxWave™ platform has proven utility in unlocking GPCRs to antibody discovery and combining Nxera’s capabilities with ...